Rang	Name	Position
1	Mr. J. D. Finley	CEO, CFO & Director
2	Dr. Mitchell Lawrence Jones M.D., Ph.D.	President & Chief Medical Officer
3	Mr. Ramesh C. Donthamsetty	Head of Corporate Development & Investor Relations
4	Dr. Joerg Heyer Ph.D.	Head of Translational Science & Medicine
5	Dr. James Izanec M.D.	VP & Head of Clinical Development
6	Mr. Daniel J. Larkins	Head of Global Regulatory Affairs
7	Mr. Adarsh Patel M.B.A., M.S.	Head of Chemistry, Manufacturing & Controls
8	Ms. Dawn Louro	VP & Head of Clinical Operations
9	Mr. Ryker Willie	Senior VP of Finance & Corporate Controller

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Soleus Capital Management, L.P.	7,52%	26,07 Mio. USD
2	Ameriprise Financial Inc	6,62%	22,97 Mio. USD
3	B Group, Inc	6,57%	22,78 Mio. USD
4	HHG PLC	6,15%	21,33 Mio. USD
5	Octagon Capital Advisors LP	5,91%	20,51 Mio. USD
6	Perceptive Advisors LLC	5,14%	17,82 Mio. USD
7	COMMODORE CAPITAL LP	4,13%	14,33 Mio. USD
8	RA Capital Management, LLC	4,10%	14,22 Mio. USD
9	Franklin Templeton Inc	3,33%	11,54 Mio. USD
10	The Goldman Sachs Group Inc	3,09%	10,72 Mio. USD
11	Boxer Capital Management, LLC	2,76%	9,58 Mio. USD
12	Morgan Stanley - Brokerage Accounts	2,62%	9,08 Mio. USD
13	Adage Capital Partners Gp LLC	2,59%	8,98 Mio. USD
14	Eversept Partners, LP	2,41%	8,35 Mio. USD
15	Wellington Management Company LLP	2,13%	7,39 Mio. USD
16	Balyasny Asset Management LLC	1,88%	6,53 Mio. USD
17	Federated Hermes Inc	1,80%	6,26 Mio. USD
18	Squadron Capital Management LLC	1,73%	5,99 Mio. USD
19	Marshall Wace Asset Management Ltd	1,58%	5,50 Mio. USD
20	Propel Bio Management LLC	1,49%	5,15 Mio. USD